Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07570602 · ClinicalTrials.gov registry record · NA
VisionApp - Refraction and Presbyopia
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT07570602 is a NA study that has completed, run by Indiana University. The registered enrollment target is 16 participants.
The verdict
NCT07570602, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
Recent Android mobile device technology is available which allows user-measured refractive error and reading add power. This technology could be quite useful to the clinical and research community. The current study aims to evaluate the accuracy, repeatability, and reproducibility of one such technology by VisionApp, specifically with regard to refraction and presbyopia. VisionApp is an app which runs on a smartphone or other device which uses the distance between the user's face and the phone to determine refractive error, while the user looks at different targets (lines, letters, words, etc).
Interventions
- DEVICE VisionApp
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2023-07-05 |
| Est. Completion | 2023-07-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07570602
The ClinicalTrials.gov registry entry for NCT07570602 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which VisionApp is the first listed.
NCT07570602 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07570602 about?
NCT07570602 is a clinical study titled "VisionApp - Refraction and Presbyopia". Recent Android mobile device technology is available which allows user-measured refractive error and reading add power. This technology could be quite useful to the clinical and research community. The current study aims to evaluate the accuracy, repeatability, and reproducibility of one such techno...
What is the current status of trial NCT07570602?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2023-07-05. Estimated completion is 2023-07-24.
What interventions are being tested in trial NCT07570602?
The interventions under investigation include: VisionApp (DEVICE).
Who is sponsoring clinical trial NCT07570602?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.